SEQENS NORTH AMERICA (FORMERLY PCI SYNTHESIS)
SEQENS North America (formerly PCI Synthesis) is a Pharmaceutical Development CDMO (Contract Development and Manufacturing Organization) based in Newburyport, Mass., a division of SEQENS, an integrated global leader in pharmaceutical synthesis and specialty ingredients with 24 manufacturing sites and 3 R&D centers in Europe, North America and Asia. SEQENS North America is also a commercial manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other ... specialty chemical products for the medical device industry. As a CDMO, SEQENS North America provides emerging and mid-sized pharmaceutical companies access to the expertise needed to develop and manufacture complex small molecules. To learn more about SEQENS North America, its proprietary NCE development activities and process R&D capabilities please visit www.seqens.com.
SEQENS NORTH AMERICA (FORMERLY PCI SYNTHESIS)
Industry:
3D Printing Health Care Manufacturing Pharmaceutical
Founded:
1995-01-01
Address:
Newburyport, Massachusetts, United States
Country:
United States
Website Url:
http://www.pcisynthesis.com
Total Employee:
101+
Status:
Active
Contact:
(978) 462-5555
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Canberra Corporation
Canberra Corporation is a chemicals company specializing in chemicals, disinfectant cleaners, and floor care products.
Coral Chemical Company
Coral Chemical Company is chemical company specializing in pre-treatment, metal working and waste water treatment solutions.
Official Site Inspections
http://www.pcisynthesis.com
- Host name: 124.194.185.35.bc.googleusercontent.com
- IP address: 35.185.194.124
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "SEQENS North America (formerly PCI Synthesis)"
PCI Synthesis - Craft
PCI Synthesis (SEQENS) is a contract development and manufacturing organization. It focuses on API (active pharmaceutical ingredient) research, development, and analytics as well as on …See details»
SEQENS North America (formerly PCI Synthesis) - Crunchbase
Contact Email [email protected] Phone Number (978) 462-5555 SEQENS North America (formerly PCI Synthesis) is a Pharmaceutical Development CDMO (Contract Development and …See details»
PCI Synthesis named as one of Inc.’s fastest growing companies
Sep 28, 2016 NEW YORK, August 17, 2016 – Inc. magazine today ranked PCI Synthesis, (www.pcisynthesis.com), a drug substance Contract Manufacturing Organization (CMO) About …See details»
Seqens North America - PitchBook
Dec 22, 2017 Information on acquisition, funding, investors, and executives for Seqens North America. Use the PitchBook Platform to explore the full profile.See details»
PCI Synthesis - Overview, News & Similar companies - ZoomInfo
Feb 6, 2019 PCI Synthesis contact info: Phone number: (978) 772-2111 Website: www.pcisynthesis.com What does PCI Synthesis do? PCI Synthesis is a custom API …See details»
PCI Synthesis - Ownership and Business Overview - Mergr
Jun 20, 2018 www.pcisynthesis.com. Profile Investors (1) ... (Contract Development and Manufacturing Organization) based in Newburyport, MA and is the largest small molecule drug …See details»
PCI Synthesis Corporate Profile | Pharmaceutical Outsourcing
Website: www.pcisynthesis.com. PCI Synthesis is one of the most awarded cGMP API manufacturing companies that offers you everything you need from initial process research to …See details»
And the top regulatory winner is…and why you should care
Mar 16, 2015 PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients. About us + Seqens …See details»
BlackArch Partners Advises PCI Synthesis on Sale to Novacap SAS
PCI Synthesis (https://www.pcisynthesis.com), headquartered in Newburyport, MA, is a leading contract developer and manufacturer (“CDMO”) of active pharmaceutical ingredients (“APIs”). …See details»
PCI Synthesis obtains DEA registration for controlled substance ...
Sep 14, 2016 PCI Synthesis a drug substance Contract Manufacturing Organization (CMO) of new chemical entities (NCEs) and generic active pharmaceutical ingredients. About us + …See details»
PCI Synthesis - VentureRadar
Goodwin Biotechnology USA n/a We are a biological contract manufacturing organization (CMO) with more than two decades of experience and expertise in the development as well as …See details»
Novacap completes the acquisition of PCI Synthesis and
Jun 28, 2018 PCI Synthesis is a Pharmaceutical Development CDMO (Contract Development and Manufacturing Organization) based in Newburyport, Mass. and is the largest small …See details»
PCI Synthesis named as one of Inc.’s fastest growing companies
Sep 28, 2016 NEW YORK, August 17, 2016 – Inc. magazine today ranked PCI Synthesis, (www.pcisynthesis.com), a drug substance Contract Manufacturing Organization (CMO) of …See details»
PCI Synthesis CEO and Key Executive Team | Craft.co
PCI Synthesis's Chief Financial Officer and Chief Operating Officer is Paul Sulloway. Other executives include Jean-Noel David, Managing Director for Seqens CDMO North America; …See details»
Successful API Development: Lessons from a CMO
Feb 1, 2017 Ed Price is President of PCI Synthesis (www.pcisynthesis.com), a pharmaceutical development Contract Manufacturing Organization (CMO) based in Newburyport, Mass. and …See details»
PCI Synthesis wins Quality, Innovation, Productivity, and Reliability ...
Mar 10, 2014 PCI Synthesis, Inc. (www.pcisynthesis.com), a Boston-based Contract Manufacturing Organization (CMO) that manufactures new chemical entities (NCE), About us …See details»
PCI Synthesis DMF, CEP, Written Confirmations, FDF
Three custom development and manufacturing organizations – PCAS S.A. in France, Chemie Uetikon in Germany and PCI Synthesis in the United States – have joined forces as Seqens …See details»
Glenn Killingworth Joins PCI Synthesis as VP of Business …
Oct 10, 2013 Glenn Killingworth Joins PCI Synthesis as VP of Business Development PCI Synthesis, Inc. (www.pcisynthesis.com), ... "We've spent the past 18 months improving our …See details»
PCI Synthesis Celebrates Key Milestones Including 4th Consecutive …
NEWBURYPORT, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical ...See details»
BlackArch Partners Advises PCI Synthesis on Sale to Novacap SAS
PCI Synthesis (https://www.pcisynthesis.com), headquartered in Newburyport, MA, is a leading contract developer and manufacturer (“CDMO”) of active pharmaceutical ingredients …See details»